Recent studies have demonstrated that low expression of MYBL2 induces cell cycle arrest, apoptosis, and epithelial–mesenchymal transition (EMT) in glioma cells, and it is positively regulated by FoxM1, a member of the forkhead box transcription factor family [18]. The gene discussed is FOXM1; the disease is central nervous system cancer.